J&J Unit Asserts Bladder Drug Patent Again
Still trying to fend off allegations of anti-competitive behavior over Ditropan XL, Johnson & Johnson subsidiary Alza Corporation has hit Mylan Laboratories Inc. with another patent infringement lawsuit involving the blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article